I don't disagree with a lot you say other than the fact about the marketing of these results to there lead up then meh nothing too fantastic. Not the best strategy on PM
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025